Phosphorylation of Bad is not essential for PKB-mediated survival signaling in hemopoietic cells

S W Wang1, T A Denny, U P Steinbrecher

  • 1Department of Medicine, University of British Columbia and Vancouver Coastal Health Research Institute, Jack Bell Research Centre, 2660 Oak St., Vancouver, BC, Canada V6H 3Z6.

Insights

Cytokine-dependent cell survival does not require Bad phosphorylation. Specifically, the PI 3-kinase/PKB pathway activation can occur independently of Bad phosphorylation at Ser136.

Area of Science:

  • Cellular and Molecular Biology
  • Immunology
  • Biochemistry

Background:

  • The protein Bad plays a crucial role in preventing apoptosis, a process critical for cell survival.
  • Phosphorylated Bad is known to inhibit apoptosis, suggesting its phosphorylation is vital for cell survival signaling.
  • The PI 3-kinase (phosphatidylinositol 3-kinase) pathway is implicated in cell survival, and its role via PKB (Protein Kinase B) in Bad phosphorylation is under investigation.

Purpose of the Study:

  • To investigate the phosphorylation of Bad at key regulatory serine residues in hemopoietic cells dependent on cytokines.
  • To determine if the survival signaling effect of the PI 3-kinase pathway is mediated by PKB phosphorylation of Bad.
  • To examine the relationship between cytokine signaling, specific Bad phosphorylation sites, and cell survival.

Main Methods:

  • Overexpression of Bad and active PKB to assess Bad phosphorylation at Ser136.
  • Analysis of endogenous Bad phosphorylation at Ser136 in MC/9 mast cells and bone marrow-derived macrophages.
  • Stimulation of cells with cytokines (IL-3, GM-CSF, IL-4) to investigate Bad phosphorylation at Ser112 and Ser155 in relation to MEK/erk and PI 3-kinase pathways.
  • Assessment of ceramide's effect on Bad phosphorylation.

Main Results:

  • Overexpression of Bad or active PKB led to increased Bad phosphorylation at Ser136.
  • Endogenous Bad phosphorylation at Ser136 was not detected in MC/9 mast cells or murine bone marrow-derived macrophages.
  • Cytokines IL-3 and GM-CSF induced Bad phosphorylation at Ser112 and Ser155, associated with MEK/erk pathway activation.
  • IL-4, activating PI 3-kinase but not MEK/erk, did not induce phosphorylation at these sites, despite promoting cell survival.
  • Ceramide did not affect Bad phosphorylation status.

Conclusions:

  • Bad phosphorylation at major regulatory sites is not essential for cytokine-dependent cell survival.
  • Activation of the PI 3-kinase/PKB pathway can be dissociated from Bad phosphorylation at Ser136.
  • Specific cytokine-induced signaling pathways differentially regulate Bad phosphorylation sites, independent of overall cell survival outcomes.

Related Concept Videos

Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...